Victory Capital Management
VRDN icon

Victory Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Victory Capital Management’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.68M Sell
188,177
-38,640
-17% -$1.15M ﹤0.01% 1425
2025
Q4 		$7.06M Sell
226,817
-205,603
-48% -$5.64M ﹤0.01% 1171
2025
Q3 		$9.33M Sell
432,420
-132,370
-23% -$2.39M 0.01% 1128
2025
Q2 		$7.9M Buy
564,790
+11,940
+2% +$162K 0.01% 1179
2025
Q1 		$7.45M Buy
552,850
+142,410
+35% +$2.43M 0.01% 1156
2024
Q4 		$7.87M Buy
+410,440
New +$8.92M 0.01% 1150
2020
Q2 		– Sell
-1,025
Closed -$6K – 3281
2020
Q1 		$6K Buy
+1,025
New +$11.9K ﹤0.01% 3449
2019
Q4 		– Sell
-264
Closed -$3K – 3275
2019
Q3 		$3K Buy
+264
New +$5.84K ﹤0.01% 3580

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return